Orally active benzamide inhibitors of p38 mitogen-activated protein kinase

被引：0

作者：

Boman, E. ^{[1
]}

Chang, A. ^{[1
]}

Ceide, S. Conde ^{[1
]}

Dahl, R. ^{[1
]}

Dalesandro, D. ^{[1
]}

Delaet, N. G. J. ^{[1
]}

Erb, E. ^{[1
]}

Ernst, J. ^{[1
]}

Gibbs, A. ^{[1
]}

Kahl, J. ^{[1
]}

Kessler, L. ^{[1
]}

Larson, C. J. ^{[1
]}

Lundstrom, J. ^{[1
]}

Miller, S. ^{[1
]}

Montalban, A. G. ^{[1
]}

Nakanishi, H. ^{[1
]}

Roberts, E. ^{[1
]}

Saiah, E. ^{[1
]}

Sullivan, R. ^{[1
]}

Wang, Z. ^{[1
]}

机构：

[1] Kemia Inc, San Diego, CA 92121 USA

来源：

INFLAMMATION RESEARCH | 2006年 / 55卷

关键词：

D O I：

暂无

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

引用

页码：S111 / S111

页数：1

共 50 条

[41] Analyzing JNK and p38 mitogen-activated protein kinase activity
Whitmarsh, AJ
Davis, RJ
REGULATORS AND EFFECTORS OF SMALL GTPASES, PT F, RAS FAMILY I, 2001, 332 : 319 - 336
[42] A meta-analysis of the role of p38 mitogen-activated protein kinase inhibitors in patients with active rheumatoid arthritis
Li, Lan
Li, Guogang
Yu, Chaohui
Li, Youming
CLINICAL RHEUMATOLOGY, 2013, 32 (12) : 1697 - 1702
[43] A meta-analysis of the role of p38 mitogen-activated protein kinase inhibitors in patients with active rheumatoid arthritis
Lan Li
Guogang Li
Chaohui Yu
Youming Li
Clinical Rheumatology, 2013, 32 : 1697 - 1702
[44] Down-regulation of p38 mitogen-activated protein kinase activation and proinflammatory cytokine production by mitogen-activated protein kinase inhibitors in inflammatory bowel disease
Docena, G.
Rovedatti, L.
Kruidenier, L.
Fanning, A.
Leakey, N. A. B.
Knowles, C. H.
Lee, K.
Shanahan, F.
Nally, K.
McLean, P. G.
Di Sabatino, A.
MacDonald, T. T.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2010, 162 (01): : 108 - 115
[45] A Diverse and Versatile Regiospecific Synthesis of Tetrasubstituted Alkylsulfanylimidazoles as p38 Mitogen-Activated Protein Kinase Inhibitors
Ansideri, Francesco
Andreev, Stanislav
Kuhn, Annette
Albrecht, Wolfgang
Laufer, Stefan A.
Koch, Pierre
MOLECULES, 2018, 23 (01):
[46] Inhibitors of p38 mitogen-activated protein kinase - Potential as anti-inflammatory agents in asthma?
Newton, R
Holden, N
BIODRUGS, 2003, 17 (02) : 113 - 129
[47] Therapeutic potential of inhaled p38 mitogen-activated protein kinase inhibitors for inflammatory pulmonary diseases
Chopra, Puneet
Kanoje, Vijay
Semwal, Arvind
Ray, Abhijit
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2008, 17 (10) : 1411 - 1425
[48] Inhibitors of p38 mitogen-activated protein kinase enhance proliferation of mouse neural stem cells
Sato, Kenichiro
Hamanoue, Makoto
Takamatsu, Ken
JOURNAL OF NEUROSCIENCE RESEARCH, 2008, 86 (10) : 2179 - 2189
[49] Do p38 mitogen-activated protein kinase inhibitors have a future for the treatment of cardiovascular disease?
Kompa, Andrew R.
JOURNAL OF THORACIC DISEASE, 2016, 8 (09) : E1068 - E1071
[50] New Inhibitors of the P38 Mitogen-Activated Protein Kinase: Repurposing Existing Drugs with Deep Learning
Vermani, Aakarsh
Kouznetsova, Valentina L.
Tsigelny, Igor F.
BIOINTERFACE RESEARCH IN APPLIED CHEMISTRY, 2022, 12 (04): : 5384 - 5404

← 1 2 3 4 5 →